Investors in the company include business people, physicians and a Silicon Valley firm, according to the report.
FloSpine’s main product focus is KeyLift, a product that relieves compression from spinal stenosis. It is the first expandable interlaminar stabilization procedure for the condition on the market, according to the devicemaker.
FloSpine was founded in 2011 and is headquartered at Florida Atlantic University. It has a team of 12. The company holds eight patents for devices geared toward the spine, including the KeyLift.
The KeyLift was developed alongside Oklahoma City-based surgeon Cheng-Lun Soo, MD, who had been using FloSpine products for several years, according to the report. The device received FDA clearance last fall and already has been used in several procedures.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
